EDGAR Filing Documents for 0001104659-17-002473

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001104659-17-002473

Filing Date

2017-01-17

Accepted

2017-01-17 09:35:15

Documents

Period of Report

2017-01-17

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	a17-2604_16k.htm	6-K	27875
2	EX-99.1	a17-2604_1ex99d1.htm	EX-99.1	19496
3	EX-99.2	a17-2604_1ex99d2.htm	EX-99.2	545518
4	EX-99.3	a17-2604_1ex99d3.htm	EX-99.3	82278
5	EX-99.4	a17-2604_1ex99d4.htm	EX-99.4	104896
6	EX-99.5	a17-2604_1ex99d5.htm	EX-99.5	81541
7	EX-99.6	a17-2604_1ex99d6.htm	EX-99.6	119933
8	GRAPHIC	g26041mw05i001.jpg	GRAPHIC	52343
9	GRAPHIC	g26041mmi001.gif	GRAPHIC	13730
	Complete submission text file	0001104659-17-002473.txt		1073790

Mailing Address ?STERGADE 24A, 1 COPENHAGEN G7 1100

Business Address ?STERGADE 24A, 1 COPENHAGEN G7 1100 0114533444242

Forward Pharma A/S (Filer) CIK: 0001604924 (see all company filings)